Amwell makes inducement grant

Company Announcement - Amwell granted 220,844 restricted stock units (RSUs) to Dan Zamansky as an inducement for his employment as chief product and technology officer [1] - The RSUs will vest 25% on the six-month anniversary of the grant date, with the remaining 75% vesting in equal increments every three months over four years [1] - If Zamansky's employment is terminated without cause or for good reason, a portion of the RSUs will vest based on the time he would have remained employed [1] Compensation Committee Approval - The RSU grant was approved by Amwell's Compensation Committee under the Inducement Plan and in accordance with NYSE's Listed Company Manual Rule 303A.08 [2] Company Overview - Amwell provides a comprehensive, technology-enabled care platform for payers and health systems, enhancing patient access to affordable and effective care [3] - The platform supports various clinical programs and aims to deliver integrated, future-ready solutions for millions of patients [3] - Amwell has been serving major healthcare organizations in the U.S. and globally for nearly two decades [3]